NCT02250105 - Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Hypertriglyceridemia

Interventions

DRUG

ARI-3037MO

Lipid lowering

DRUG

Placebo

Inactive

Trial Locations (5)

National Clinical Research inc, Richmond

Louisville Metabolic and Atherosclerosis Research Center, Louisville

Sterling Clinical Research Inc, Cincinnati

Orange County Research Center, Tustin

Maine Research Associates, Auburn